press releases

Supports closer engagement with scientists in North America, to meet growing international adoption of its Amperia protein quantification platform Cambridge, UK, and Cambridge, US, 9 March 2026:   Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, today announced that it has established a US subsidiary at The Engine in Cambridge, MA. The new location strengthens its presence in the North American life sciences ecosystem,

Drs Giulia Kennedy, Arnold Levine, John Sninsky, Martin Goldberg and Prof Tin Tin Su join SAB Follows close of initial funding round with investment from Stephen Quake and Jay Flatley Irvine, California, and Daresbury, UK, 2 March 2026:   Wisdom Bioscience, Inc., a biotechnology company pioneering non-invasive oral cancer diagnostics, today announced the formation of its Scientific Advisory Board (SAB) following the close of an initial funding round. The SAB is comprised of l

Strengthens leadership team to support next phase of growth as organisation evolves to meet needs of global drug discovery community Drs Gray and Duncan to lead scientific programmes and early career initiatives, respectively Cambridge, UK, 25 February 2026:  ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, has strengthened its leadership team with the appointment of Drs Kelly Gray and Elaine Duncan to its Board. These new